Primary care physician, oncologist, and psychiatrist comfort levels with prescriptions written by themselves and peers for cancer comorbidities
Conferences
Chou, C; Hohmann, NS; Hastings, T; Li, C; Farley, J; Maciejewski, M; Domino, M; Hansen, R
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
August 1, 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
August 1, 2018
Volume
27
Start / End Page
513 / 513
Publisher
WILEY
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Chou, C., Hohmann, N. S., Hastings, T., Li, C., Farley, J., Maciejewski, M., … Hansen, R. (2018). Primary care physician, oncologist, and psychiatrist comfort levels with prescriptions written by themselves and peers for cancer comorbidities. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 27, pp. 513–513). WILEY.
Chou, Chiahung, Natalie S. Hohmann, Tessa Hastings, Chao Li, Joel Farley, Matthew Maciejewski, Marisa Domino, and Richard Hansen. “Primary care physician, oncologist, and psychiatrist comfort levels with prescriptions written by themselves and peers for cancer comorbidities.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 27:513–513. WILEY, 2018.
Chou C, Hohmann NS, Hastings T, Li C, Farley J, Maciejewski M, et al. Primary care physician, oncologist, and psychiatrist comfort levels with prescriptions written by themselves and peers for cancer comorbidities. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY; 2018. p. 513–513.
Chou, Chiahung, et al. “Primary care physician, oncologist, and psychiatrist comfort levels with prescriptions written by themselves and peers for cancer comorbidities.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 27, WILEY, 2018, pp. 513–513.
Chou C, Hohmann NS, Hastings T, Li C, Farley J, Maciejewski M, Domino M, Hansen R. Primary care physician, oncologist, and psychiatrist comfort levels with prescriptions written by themselves and peers for cancer comorbidities. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY; 2018. p. 513–513.
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
August 1, 2018
Volume
27
Start / End Page
513 / 513
Publisher
WILEY
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences